Fondazione Italiana Linfomi - Ets

This study tested whether adding the drug venetoclax to standard chemotherapy (R-BAC) helps older patients with high-risk mantle cell lymphoma live longer without their cancer getting worse. The trial involved 141 patients aged 65 and older (or younger if unable to have a transpl…

This study looked back at the medical records of 633 adults with a rare type of lymphoma (PMBCL) treated between 2007 and 2019. The goal was to see how well different treatments worked, how often the disease came back, and what side effects patients experienced. No new treatments…

This study reviewed PET scans from 200 adults with mantle cell lymphoma to see if they could improve staging and outcome predictions compared to standard CT scans and bone marrow biopsies. Researchers analyzed scans taken at diagnosis, after initial treatment, and after stem cell…

This study followed 127 people with diffuse large B-cell lymphoma who were treated with a common chemotherapy regimen called R-CHOP. The main goal was to track heart-related side effects caused by the chemotherapy drug doxorubicin. Researchers measured how often heart problems oc…

This study looked at whether genetic mutations linked to Waldenström's macroglobulinemia can be detected in blood or urine samples instead of bone marrow biopsies. Researchers enrolled 300 patients to compare results from these less invasive tests with the standard bone marrow me…

This study looked at 100 adults with cutaneous T-cell lymphoma (CTCL) who had already tried at least one other treatment. Researchers wanted to see how well the drug mogamulizumab works in everyday medical practice, not just in controlled trials. They measured how many patients h…